Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
News
Sports
TV & Film
About Us
Contact Us
Copyright
© 2024 PodJoint
Podjoint Logo
US
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/PodcastSource122/v4/6c/19/73/6c1973ce-7ae0-f680-0f1f-f5d4c7c07d3f/bdab3184-5c49-44af-b97a-85d3418dee6c.png/600x600bb.jpg
Q&A with FDA
U.S. Food and Drug Administration, Center for Drug Evaluation and Research
20 episodes
9 months ago
"Q&A with FDA" provides engaging conversation and discussion about the latest regulatory topics. In this podcast series, FDA’s Division of Drug Information will answer some of the most commonly asked questions received by FDA.
Show more...
Medicine
Government,
Health & Fitness,
Science,
Life Sciences
RSS
All content for Q&A with FDA is the property of U.S. Food and Drug Administration, Center for Drug Evaluation and Research and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
"Q&A with FDA" provides engaging conversation and discussion about the latest regulatory topics. In this podcast series, FDA’s Division of Drug Information will answer some of the most commonly asked questions received by FDA.
Show more...
Medicine
Government,
Health & Fitness,
Science,
Life Sciences
Episodes (20/20)
Q&A with FDA
Recognizing and Reporting Potentially False or Misleading Prescription Drug Promotion with Dr. Catherine Gray
11 months ago
14 minutes

Q&A with FDA
Understanding Drug Recalls with Dr. Ileana Elder
1 year ago
25 minutes

Q&A with FDA
Utilizing Generic Drug Awareness to Improve Patient Outcomes with Dr. Sarah Ibrahim
1 year ago
23 minutes 30 seconds

Q&A with FDA
Real-World Data and Evidence Generation with Dr. Hilary Marston
1 year ago
21 minutes

Q&A with FDA
The Role of Artificial Intelligence in Clinical Trial Design and Research with Dr. ElZarrad
1 year ago
23 minutes 58 seconds

Q&A with FDA
Switching Between Biosimilars and Their Reference Counterparts with Dr. Sarah Yim
1 year ago
12 minutes 13 seconds

Q&A with FDA
The Current Status of Oral Phenylephrine as a Nasal Decongestant with Dr. Theresa Michele and Dr. Ilisa Bernstein
1 year ago
16 minutes 14 seconds

Q&A with FDA
Medication Health Fraud and Avoiding Medication Scams with Cynthia Ng
1 year ago
15 minutes 29 seconds

Q&A with FDA
FDA’s Regulation of Dietary Supplements with Dr. Cara Welch
1 year ago
13 minutes 29 seconds

Q&A with FDA
A Step Forward in the Treatment of Opioid and Alcohol Dependence with Dr. Iilun Murphy and Dr. Marta Sokolowska
2 years ago
8 minutes 59 seconds

Q&A with FDA
Navigating the World of Online Pharmacies with CDR Lysette Deshields
2 years ago
9 minutes 29 seconds

Q&A with FDA
CURE ID, A Tool for Clinicians to Report New Uses of Existing Drugs with Heather Stone and Dr. Marco Schito
2 years ago
19 minutes 58 seconds

Q&A with FDA
FDA takes steps to decrease barriers for overdose reversal agents with Dr. Marta Sokolowska
2 years ago
11 minutes 59 seconds

Q&A with FDA
Drug Shortages with CDR Emily Thakur
2 years ago
11 minutes 29 seconds

Q&A with FDA
Generics-at-a-Glance with Dr. Sarah Ibrahim
2 years ago
9 minutes 59 seconds

Q&A with FDA
Expanded Access with Dr. Jacqueline Corrigan-Curay
2 years ago
13 minutes 14 seconds

Q&A with FDA
MedWatch, Your Report Can Make a Difference
2 years ago
11 minutes 19 seconds

Q&A with FDA
FDA’s Overdose Prevention Framework with Dr. Marta Sokolowska
3 years ago
7 minutes 29 seconds

Q&A with FDA
Clinical Trial Basics
3 years ago
12 minutes 28 seconds

Q&A with FDA
Conversation on Paxlovid
3 years ago
14 minutes 46 seconds

Q&A with FDA
"Q&A with FDA" provides engaging conversation and discussion about the latest regulatory topics. In this podcast series, FDA’s Division of Drug Information will answer some of the most commonly asked questions received by FDA.